SUPPORTING
INDEPENDENT RHEUMATOLOGY
ABOUT UNITED RHEUMATOLOGY
United Rheumatology is the pre-eminent rheumatology care management organization empowering rheumatologists to advance the standard of care while leading in the development of value-based precision medicine.
FEATURED RESOURCE
Group Purchasing
UR-GPO has contracted with pharmaceutical manufacturers to provide highly-competitive prices for pharmaceuticals, biologics and biosimilars.
FEATURED RESOURCE
Group Purchasing
UR-GPO has contracted with pharmaceutical manufacturers to provide highly-competitive prices for pharmaceuticals, biologics and biosimilars.
Unity is strength. I cannot imagine going alone in my journey as a solo private Rheumatologist. Wonderful things can be achieved with teamwork and collaboration. Success and growth are never by chance or when standing alone. They are the result of working United together!
LATEST NEWS
Clinical Trial open to United Rheumatology Members Beginning in June, Scipher Medicine will begin enrolling UR member sites for a trial called NETWORK-004: A Prospective Observational Trial to Validate the Ability of PrismRA to Predict Non-Responders to anti-TNF Therapies. The primary endpoint of this study is the predictive ability of the PrismRA response classifier to identify … Read moreClinical Trial open to United Rheumatology Members
Read More
LATEST NEWS
Clinical Trial open to United Rheumatology Members Beginning in June, Scipher Medicine will begin enrolling UR member sites for a trial called NETWORK-004: A Prospective Observational Trial to Validate the Ability of PrismRA to Predict Non-Responders to anti-TNF Therapies. The primary endpoint of this study is the predictive ability of the PrismRA response classifier to identify … Read moreClinical Trial open to United Rheumatology Members
Read MoreNot a Member Yet?
United Rheumatology is the pre-eminent rheumatology care management organization empowering rheumatologists to advance the standard of care while leading in the development of value-based precision medicine.